Physician

Manmeet Singh Ahluwalia, DO

According to 2025 Medicare claims, Manmeet Ahluwalia, DO (NPI: 1053706168) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07731-3319. Ahluwalia is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Ahluwalia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 637 traditional Medicare patients, billed 137,077 HCPCS/CPT codes, and received $1,916,895 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 292 prescription claims across 70 beneficiaries totaling $254,972 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 125 claims. Open Payments data shows 23 records totaling $596. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $27,595 to $1,916,895. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,501 to $254,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	180	393	$27,595
2020	79	136	$8,965
2021	68	126	$9,529
2022	186	442	$36,427
2023	357	30,124	$465,084
2024	637	137,077	$1,916,895

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	98	$2,501
2016	53	314	$15,658
2017	36	196	$12,051
2018	50	204	$140,095
2019	69	220	$330,720
2020	53	192	$598,302
2021	74	184	$280,618
2022	123	520	$1,229,532
2023	125	589	$2,062,214
2024	70	292	$254,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	36	$891
2023	N/R	125	$7,932
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	229	261	$137
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	239	671	$64
96367	Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	115	415	$23
36415	Insertion of needle into vein for collection of blood sample	275	687	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	271	694	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	23	900	$17,013
Prochlorperazine Maleate	Prochlorperazine Maleate	27	372	$534
Dexamethasone	Dexamethasone	26	331	$439
Ondansetron Hcl	Ondansetron Hcl	43	662	$270
Hydroxyurea	Hydroxyurea	13	390	$176

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$596	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manmeet Singh Ahluwalia, DO?

Tedicare shows public-source Medicare data for Manmeet Singh Ahluwalia, DO (NPI 1053706168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manmeet Singh Ahluwalia, DO have ACO affiliation data?

Manmeet Singh Ahluwalia, DO is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Manmeet Singh Ahluwalia, DO?

Manmeet Singh Ahluwalia, DO is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Manmeet Singh Ahluwalia, DO have Open Payments data?

Manmeet Singh Ahluwalia, DO has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.